FDA Inspection 1313232 — Eric B.J. Segal, M.D.
The FDA completed an inspection of Eric B.J. Segal, M.D. on Apr 2, 2026 in Hackensack, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 2, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hackensack, NJ (United States)
Additional Details
Clinical Investigator (CI)